Annual Working Capital
$190.71 M
-$47.92 M-20.08%
December 31, 2024
Summary
- As of March 15, 2025, MLYS annual working capital is $190.71 million, with the most recent change of -$47.92 million (-20.08%) on December 31, 2024.
- During the last 3 years, MLYS annual working capital has risen by +$184.64 million (+3042.80%).
- MLYS annual working capital is now -20.08% below its all-time high of $238.62 million, reached on December 31, 2023.
Performance
MLYS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$190.71 M
-$45.71 M-19.33%
December 31, 2024
Summary
- As of March 15, 2025, MLYS quarterly working capital is $190.71 million, with the most recent change of -$45.71 million (-19.33%) on December 31, 2024.
- Over the past year, MLYS quarterly working capital has dropped by -$47.92 million (-20.08%).
- MLYS quarterly working capital is now -41.79% below its all-time high of $327.62 million, reached on March 31, 2024.
Performance
MLYS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
MLYS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.1% | -20.1% |
| 3 y3 years | +3042.8% | -20.1% |
| 5 y5 years | +5372.5% | -20.1% |
MLYS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.1% | +3042.8% | -41.8% | +82.1% |
| 5 y | 5-year | -20.1% | +5372.5% | -41.8% | +3042.8% |
| alltime | all time | -20.1% | +5372.5% | -41.8% | +3042.8% |
Mineralys Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $190.71 M(-20.1%) | $190.71 M(-19.3%) |
| Sep 2024 | - | $236.41 M(-18.4%) |
| Jun 2024 | - | $289.60 M(-11.6%) |
| Mar 2024 | - | $327.62 M(+37.3%) |
| Dec 2023 | $238.62 M | $238.62 M(-5.2%) |
| Sep 2023 | - | $251.83 M(-4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $263.28 M(-0.5%) |
| Mar 2023 | - | $264.71 M(+152.7%) |
| Dec 2022 | $104.74 M(+1626.2%) | $104.74 M(-8.7%) |
| Sep 2022 | - | $114.67 M(+1789.7%) |
| Dec 2021 | $6.07 M(-267.8%) | - |
| Dec 2021 | - | $6.07 M |
| Dec 2020 | -$3.62 M | - |
FAQ
- What is Mineralys Therapeutics annual working capital?
- What is the all time high annual working capital for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual working capital year-on-year change?
- What is Mineralys Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly working capital year-on-year change?
What is Mineralys Therapeutics annual working capital?
The current annual working capital of MLYS is $190.71 M
What is the all time high annual working capital for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual working capital is $238.62 M
What is Mineralys Therapeutics annual working capital year-on-year change?
Over the past year, MLYS annual working capital has changed by -$47.92 M (-20.08%)
What is Mineralys Therapeutics quarterly working capital?
The current quarterly working capital of MLYS is $190.71 M
What is the all time high quarterly working capital for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly working capital is $327.62 M
What is Mineralys Therapeutics quarterly working capital year-on-year change?
Over the past year, MLYS quarterly working capital has changed by -$47.92 M (-20.08%)